The Mechanistic Study of Melatonin Regulation of p16Ink4a and Oct4 in Anti‐Cellular Senescence
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Yang Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Melatonin, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Octamer Transcription Factor-3. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Melatonin is a multifunctional indole hormone with established roles in anti‐aging and tissue regeneration. Although it has been shown to modulate key senescence‐associated markers such as p16Ink4a (p16) and OCT4, the underlying molecular mechanisms remain incompletely understood. MC3T3‐E1 cells were treated with melatonin to evaluate its effects on p16 and OCT4 expression using Western blot and RT‐qPCR. Isothermal titration calorimetry (ITC) and molecular docking were employed to investigate protein–protein interactions and structural binding patterns. VDR knockdown experiments were performed to assess functional causality. In addition, osteogenic differentiation was evaluated in bone marrow‐derived mesenchymal stem cells (BMSCs) using alkaline phosphatase (ALP) and Alizarin Red S (ARS) staining. Melatonin significantly downregulated p16 and upregulated OCT4 expression without affecting cell viability. ITC analysis revealed that melatonin does not directly bind to p16 or OCT4, but both proteins interact with the vitamin D receptor (VDR) with moderate affinity. Molecular docking further supported stable binding conformations between VDR and p16/OCT4. Functionally, VDR knockdown disrupted the balance of p16 and OCT4 expression and impaired osteogenic differentiation, as evidenced by decreased ALP activity and reduced mineralized nodule formation. These findings identify VDR as a critical mediator of melatonin signalling and reveal a novel VDR‐centered regulatory axis linking senescence and stemness pathways. This mechanism provides new insights into the anti‐senescence and pro‐regenerative effects of melatonin and suggests potential therapeutic strategies for aging‐related diseases such as osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
ORCID-Profile: Xiaoyu Chen
Zitieren
APA
Xu, Y., Zhang, C., Wang, L., & Chen, X. (2026). The Mechanistic Study of Melatonin Regulation of p16Ink4a and Oct4 in Anti‐Cellular Senescence. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71321
Vancouver
Xu Y, Zhang C, Wang L, Chen X. The Mechanistic Study of Melatonin Regulation of p16Ink4a and Oct4 in Anti‐Cellular Senescence. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71321
BibTeX
@article{Xu2026,
author = {Xu, Yang and Zhang, Cong and Wang, Li and Chen, Xiaoyu},
title = {The Mechanistic Study of Melatonin Regulation of p16Ink4a and Oct4 in Anti‐Cellular Senescence},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71321}
}
EUVIMED